Latest News and Press Releases
Want to stay updated on the latest news?
-
Announces receipt of all regulatory approvals required to complete acquisition of Actelion ALLSCHWIL/BASEL, SWITZERLAND - 09 June 2017 - Johnson & Johnson (NYSE:JNJ) today announced that,...
-
Announces receipt of all regulatory approvals required to complete acquisition of Actelion ALLSCHWIL/BASEL, SWITZERLAND - 09 June 2017 - Johnson & Johnson (NYSE:JNJ) today announced that,...
-
ALLSCHWIL, SCHWEIZ - 08. Juni 2017 - Actelion Ltd gab heute ein Update zum Phase-III-Programm IMPACT zur Ermittlung der Wirksamkeit und Sicherheit des neuartigen Antibiotikums Cadazolid im...
-
ALLSCHWIL, SWITZERLAND - 08 June 2017 - Actelion Ltd (SIX: ATLN) today provided an update on the Phase III program IMPACT to investigate the efficacy and safety of Actelion's novel anti-infective...
-
Positive Ergebnisse einer Dosisfindungsstudie mit ACT-132577 - Kandidat für die Weiterentwicklung in Phase 3 bei therapieresistenter HypertoniePositive Sicherheitsstudie mit Cenerimod - Kandidat für...
-
Positive dose-finding results with ACT-132577 - asset to progress to Phase 3 development in resistant hypertensionPositive safety study with cenerimod - asset to progress into larger Phase 2...
-
ALLSCHWIL/BASEL, SWITZERLAND - 15 May 2017 - Actelion Ltd (SIX: ATLN) today announced changes to its executive team that would only take effect upon closing of the transaction with Johnson &...
-
ALLSCHWIL/BASEL, SWITZERLAND - 15 May 2017 - Actelion Ltd (SIX: ATLN) today announced changes to its executive team that would only take effect upon closing of the transaction with Johnson &...
-
Transaction remains on track to close towards the end of the second quarter of 2017 ALLSCHWIL, SWITZERLAND - 27 April 2017 - Actelion Ltd (SIX: ATLN) today announced that Janssen Holding GmbH, a...
-
Transaction remains on track to close towards the end of the second quarter of 2017 ALLSCHWIL, SWITZERLAND - 27 April 2017 - Actelion Ltd (SIX: ATLN) today announced that Janssen Holding GmbH, a...